Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective,2-Year Post-Trial Follow-up Study of Sustained and Rebound Effect of Red-light Therapy for Myopia in Ningbo.

NCT06232161 is registered in ClinicalTrials.gov with Beijing Airdoc Technology Co., Ltd. as lead sponsor.

NCT NCT06232161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06232161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective,2-Year Post-Trial Follow-up Study of Sustained and Rebound Effect of Red-light Therapy for Myopia in Ningbo.
Lead sponsor
Beijing Airdoc Technology Co., Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 13, 2020
Completion date
December 31, 2026
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia